Filing Details

Accession Number:
0001179110-21-002812
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 20:07:19
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 20:07:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375088 C Adam Vandervoort C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Legal Officer, Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 3,745 $0.00 3,945 No 4 M Direct
Common Stock Disposition 2021-03-02 1,658 $224.28 2,287 No 4 S Direct
Common Stock Acquisiton 2021-03-02 1,941 $0.00 4,228 No 4 M Direct
Common Stock Acquisiton 2021-03-02 3,300 $0.00 7,528 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-03-01 3,745 $0.00 3,745 $0.00
Common Stock Restricted Stock Units Disposition 2021-03-02 1,941 $0.00 1,941 $0.00
Common Stock Performance Stock Units Acquisiton 2021-03-02 9,900 $0.00 9,900 $0.00
Common Stock Performance Stock Units Disposition 2021-03-02 3,300 $0.00 3,300 $0.00
Common Stock Restricted Stock Units Acquisiton 2021-03-02 5,736 $0.00 5,736 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
3,883 No 4 M Direct
9,900 No 4 A Direct
6,600 No 4 M Direct
5,736 No 4 A Direct
Footnotes
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  4. On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  5. On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  6. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  7. Performance award amount determined based on metrics in respect of the issuer's 2020 financial results.
  8. The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021.
  9. On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
  10. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  11. The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date.